Publications found:
36,576
Sort by:
Fill Finish Manufacturing Market Size, Share, and Analysis, By Product [Consumables (Prefilled Syringes, Glass Vials/Plastic Vials, Cartridges), Instruments, and Automated Machines], By Modality (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others), and By End User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Fill Finish Manufacturing Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 40.3 bi...
December 2024
573 pages
Vaccines Market Size, Share, and Analysis, By Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, and mRNA), By Type (Monovalent and Multivalent), By Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, and RSV), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Vaccines Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 66.4 billion and is proj...
December 2024
560 pages
Intraocular Lymphoma Treatment Market - 2024-2031
US$ 3,400.00
The Intraocular Lymphoma Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
November 2024
56 pages
Guillain-Barre Syndrome Treatment Market - 2024-2031
US$ 3,400.00
Guillain-Barre Syndrome Treatment Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Guillain-Barre Syndrome Treatment Market emerges as a key focus in DataM Intelligen...
November 2024
59 pages
Triptorelin Market - 2024-2031
US$ 3,400.00
Triptorelin Marketis is growing with a CAGR of 4.70% during the forecast period 2026-2035. The Triptorelin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
November 2024
37 pages
Vulvodynia Treatment Market - 2024-2031
US$ 3,400.00
The Vulvodynia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2024
46 pages
Antibody-Mediated Rejection Market - 2024-2031
US$ 3,400.00
Antibody-Mediated Rejection Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The Antibody-Mediated Rejection Market emerges as a key focus in DataM Intelligence latest in...
November 2024
53 pages
Marfan Syndrome Treatment Market - 2024-2031
US$ 3,400.00
Marfan Syndrome Treatment Market reached US$ 203.5 million in 2023 and is expected to reach US$ 312.6 million by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Marfan Syn...
November 2024
51 pages
Edaravone Market - 2024-2031
US$ 3,400.00
The Edaravone Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled m...
November 2024
35 pages
Acetylcysteine Market - 2024-2031
US$ 3,400.00
The Acetylcysteine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
November 2024
40 pages
Hyperphosphatemia Treatment Market - 2024-2031
US$ 3,400.00
The Hyperphosphatemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
November 2024
53 pages
Real-World Evidence Solutions Market - 2024-2031
US$ 3,400.00
The Real-World Evidence Solutions Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
November 2024
55 pages
Bile Duct Cancer Treatment Market - 2024-2031
US$ 3,400.00
Bile Duct Cancer Treatment Marketis is growing with a CAGR of 8.50% during the forecast period 2026-2035. The Bile Duct Cancer Treatment Market emerges as a key focus in DataM Intelligence latest in-d...
November 2024
52 pages
Neuroblastoma Drugs Market - 2024-2031
US$ 3,400.00
The Neuroblastoma Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
November 2024
45 pages
Contraceptive Drugs Market - 2024-2031
US$ 3,400.00
Contraceptive Drugs Marketis is growing with a CAGR of 6.60% during the forecast period 2026-2035. The Contraceptive Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
November 2024
45 pages
Acetylcholinesterase Inhibitors Market - 2024-2031
US$ 3,400.00
Acetylcholinesterase Inhibitors Market reached US$ 5.03 billion in 2023 and is expected to reach US$ 9.03 billion by 2031, growing with a CAGR of 7.80% during the forecast period 2026-2031. The Acetyl...
November 2024
57 pages
Eosinophilic Disorders Market - 2024-2031
US$ 3,400.00
Eosinophilic Disorders Market reached US$ 150 million in 2023 and is expected to reach US$ 278 million by 2031, growing with a CAGR of 7.10% during the forecast period 2026-2031. The Eosinophilic Diso...
November 2024
48 pages
Myotonic Dystrophy Treatment Market - 2024-2031
US$ 3,400.00
The Myotonic Dystrophy Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
November 2024
54 pages
Menopause Treatment Market - 2024-2031
US$ 3,400.00
Menopause Treatment Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Menopause Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
November 2024
45 pages
Gamma-Aminobutyric Acid (GABA) Receptor Market - 2024-2031
US$ 3,400.00
Gamma-Aminobutyric Acid (GABA) Receptor Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Gamma-Aminobutyric Acid (GABA) Receptor Market emerges as a key focus in Data...
November 2024
65 pages
Tramadol Drugs Market - 2024-2031
US$ 3,400.00
The Tramadol Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
November 2024
40 pages
Dyspareunia Drugs Market - 2024-2031
US$ 3,400.00
The Dyspareunia Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
November 2024
43 pages
Erdosteine Market - 2024-2031
US$ 3,400.00
The Erdosteine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
November 2024
36 pages
Diverticulitis Disease Treatment Market - 2024-2031
US$ 3,400.00
Diverticulitis Disease Treatment Marketis is growing with a CAGR of 7.70% during the forecast period 2026-2035. The Diverticulitis Disease Treatment Market emerges as a key focus in DataM Intelligence...
November 2024
58 pages
Hematuria Treatment Market - 2024-2031
US$ 3,400.00
Hematuria Treatment Marketis is growing with a CAGR of 2.80% during the forecast period 2026-2035. The Hematuria Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
November 2024
45 pages
Hemochromatosis Treatment Market - 2024-2031
US$ 3,400.00
Hemochromatosis Treatment Marketis is growing with a CAGR of 5.70% during the forecast period 2026-2035. The Hemochromatosis Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
November 2024
51 pages
Interstitial Cystitis Drugs Market - 2024-2031
US$ 3,400.00
Interstitial Cystitis Drugs Marketis is growing with a CAGR of 5.28% during the forecast period 2026-2035. The Interstitial Cystitis Drugs Market emerges as a key focus in DataM Intelligence latest in...
November 2024
53 pages
Injectables Contraceptives Market - 2024-2031
US$ 3,400.00
The Injectables Contraceptives Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
November 2024
52 pages
Fragile X Syndrome (Fxs) Treatment Market - 2024-2031
US$ 3,400.00
Fragile X Syndrome (Fxs) Treatment Marketis is growing with a CAGR of 6.80% during the forecast period 2026-2035. The Fragile X Syndrome (Fxs) Treatment Market emerges as a key focus in DataM Intellig...
November 2024
60 pages
Mitochondrial Myopathies Treatment Market - 2024-2031
US$ 3,400.00
The Mitochondrial Myopathies Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
November 2024
60 pages
Yeast Infection Treatment Market - 2024-2031
US$ 3,400.00
Yeast Infection Treatment Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Yeast Infection Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
November 2024
51 pages
Testicular Cancer Market - 2024-2031
US$ 3,400.00
Testicular Cancer Market reached USD 811.3 million in 2023 and is expected to reach USD 1,246.3 million by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Testicular Cance...
November 2024
43 pages
Diabetic Gastroparesis Treatment Market - 2024-2031
US$ 3,400.00
Diabetic Gastroparesis Treatment Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Diabetic Gastroparesis Treatment Market emerges as a key focus in DataM Intelligence...
November 2024
58 pages
Ursodeoxycholic Acid Market - 2024-2031
US$ 3,400.00
Ursodeoxycholic Acid Market reached US$ 581.17 million in 2023 and is expected to reach US$ 1120.55 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The Ursodeoxycho...
November 2024
46 pages
Capecitabine Market - 2024-2031
US$ 3,400.00
The Capecitabine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
November 2024
38 pages
Europe Leukemia Therapeutics Market - 2024-2031
US$ 2,499.00
Europe Leukemia Therapeutics Market reached US$ 4.7 billion in 2023 and is expected to reach US$ 7.56 billion by 2031, growing with a CAGR of 6.30% during the forecast period 2026-2031. The Europe Leu...
November 2024
54 pages
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
Antiplatelet drugs prevent platelets from sticking together and decrease the body’s ability to form blood clots. These medications are used to treat, and may help prevent, heart attack, abnormal heart...
November 2024
146 pages
Taxanes Market - 2024-2031
US$ 3,400.00
The Taxanes Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled mar...
November 2024
33 pages
Nephrotic Syndrome Drugs Market - 2024-2031
US$ 3,400.00
Nephrotic Syndrome Drugs Market reached US$ 423.7 million in 2023 and is expected to reach US$ 645.3 million by 2031, growing with a CAGR of 5.40% during the forecast period 2026-2031. The Nephrotic S...
November 2024
50 pages
Asia Pacific Leukemia Therapeutics Market - 2024-2031
US$ 2,499.00
Asia Pacific Leukemia Therapeutics Market reached US$ 340 million in 2023 and is expected to reach US$ 567.18 million by 2031, growing with a CAGR of 6.70% during the forecast period 2026-2031. The As...
November 2024
60 pages
Synovial Sarcoma Treatment Market - 2024-2031
US$ 3,400.00
Synovial Sarcoma Treatment Market reached US$ 832.47 million in 2023 and is expected to reach US$ 1646.61 million by 2031, growing with a CAGR of 8.90% during the forecast period 2026-2031. The Synovi...
November 2024
52 pages
Chronic Kidney Disease Drugs Market - 2024-2031
US$ 3,400.00
Chronic Kidney Disease Drugs Market reached US$ 10,923.29 million in 2021 and is expected to reach US$ 19,427.41 million by 2031, growing with a CAGR of 6.60% during the forecast period 2026-2031. The...
November 2024
54 pages
Basal Insulin (Long-Acting Insulin) Market - 2024-2031
US$ 3,400.00
Basal Insulin (Long-Acting Insulin) Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Basal Insulin (Long-Acting Insulin) Market emerges as a key focus in DataM Intell...
November 2024
61 pages
Single-use Technologies for Biopharmaceuticals: Global Markets
US$ 4,650.00
... An overview of the global market for single-use technologies for the biopharmaceutical industry Analyses of global market trends, with data from 2018 ... and key factors influencing the single-use technologies and bioreactors for pharmaceuticals Quantification of market applications, such as monoclonal antibodies ...
November 2024
207 pages
Dronabinol Market - 2024-2031
US$ 3,400.00
The Dronabinol Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
November 2024
36 pages
